St. Petersburg State Pavlov Medical University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Notable: APTBCy · Optimization of Post-transplantation Benadamustine and Cyclophosphamide · High-risk Myeloid Malignancies and a Partially Mismatched Donor Primary and study completion pushed from Dec 10, 2026 to Dec 10, 2027
- Minor: VitaStem · Vitamin A and D Supplementation in Allogeneic HCT Enrollment closed, study ongoing
- Notable: NICE-40 · PET-Adapted Low-Dose Nivolumab With NICE-40 for Relapsed/Refractory Classical Hodgkin Lymphoma Phase changed: Phase 1/2 → Phase 2
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-29 | NCT07904117 Russian Version of OHIP-EDENT-19 for Adults With Complete Tooth Loss | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 7 |
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 11
Acute Myeloid Leukemia (AML) (4) · Leukemia (4) · Myelodysplastic Syndromes (MDS) (4) · Chronic Myeloid Leukemia (CML) (3) · Hodgkin Lymphoma (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Non-Hodgkin Lymphoma (2) · DLBCL (1) · Gastric Cancer (1) · MDS/MPN Overlap (1)
Get alerts when St. Petersburg State Pavlov Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.